+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

L-Isoleucine

BP3541
73-32-5
L-isoleucine is the L-enantiomer of isoleucine. It has a role as a mouse metabolite, a Saccharomyces cerevisiae metabolite, a plant metabolite, an Escherichia coli metabolite, a human metabolite and an algal metabolite. It is a L-alpha-amino acid, an aspartate family amino acid, an isoleucine and a proteinogenic amino acid. It is a conjugate base of a L-isoleucinium. It is a conjugate acid of a L-isoleucinate. It is an enantiomer of a D-isoleucine. It is a tautomer of a L-isoleucine zwitterion. L-Isoleucine often impacts muscle repair function, cirrhosis, obesity, cardiovascular disease, glucose and lipid metabolism, blood glucose levels and other conditions. L-Isoleucine administration can regulate the inflammatory response to protect against pathogens in vivo and in vitro, making it for research in dextran sulfate sodium (DSS) (HY-116282) -induced colitis.
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

NFKB1 MTOR TJP1
MTOR EIF4EBP1 RPS6KB1 RPTOR MLST8
MTOR FOXO3 EIF4EBP1 RPS6KB1
GLUL

L-Isoleucine Related Products

Product drug property prediction parameters

  • 63.3200

  • .0104

  • .0065

  • 64.1110

  • .4282

  • 3.1096

  • Low

  • 19.4085

  • 2.8160

  • Yes

  • Yes

  • No

  • No

  • No

  • No

  • 0.0

  • No

  • No

  • No

  • No